MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering ...

HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure ...

Interim results from a study in China suggest ivonescimab may reduce the risk of death versus Keytruda, but the difference ...